Short Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Expands By 94.5%

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 7,780,000 shares, an increase of 94.5% from the December 15th total of 4,000,000 shares. Approximately 4.2% of the company’s shares are sold short. Based on an average daily volume of 100,730,000 shares, the short-interest ratio is presently 0.1 days.

Tonix Pharmaceuticals Price Performance

Shares of NASDAQ TNXP opened at $0.26 on Tuesday. The company has a market capitalization of $47.92 million, a PE ratio of 0.00 and a beta of 2.02. The company has a quick ratio of 2.81, a current ratio of 3.33 and a debt-to-equity ratio of 0.07. The stock’s 50 day moving average price is $0.25 and its 200-day moving average price is $0.31. Tonix Pharmaceuticals has a twelve month low of $0.12 and a twelve month high of $12.48.

Tonix Pharmaceuticals (NASDAQ:TNXP) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($2.03) by $1.80. The firm had revenue of $2.82 million for the quarter, compared to analysts’ expectations of $2.63 million. Tonix Pharmaceuticals had a negative net margin of 1,197.86% and a negative return on equity of 163.95%. On average, equities analysts anticipate that Tonix Pharmaceuticals will post -17.63 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on Tonix Pharmaceuticals in a research note on Thursday, January 9th. They issued a “hold” rating for the company.

About Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.